Funder
Novartis Pharma AG, Basel, Switzerland
Subject
Pharmacology (medical),Biochemistry, medical,Pulmonary and Respiratory Medicine
Reference51 articles.
1. Which is the optimal bronchodilator therapy for chronic obstructive pulmonary disease?;Baloira;Expet Rev. Respir. Med.,2013
2. Global Initiative for Chronic Obstructive Lung Disease (GOLD): Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. [http://www.goldcopd.com].
3. Combination bronchodilator therapy in the management of chronic obstructive pulmonary disease;Tashkin;Respir. Res.,2013
4. Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD;Price;Prim. Care Respir. J.,2013
5. Inhaled corticosteroids in chronic obstructive pulmonary disease;Suissa;Proc. Am. Thorac. Soc.,2007
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献